Announcements Trials
Browse Landscape

Status

Completed 6Unknown 5Recruiting 4Enrolling by invitation 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Breast Neoplasms 141Neoplasms 132Prostatic Neoplasms 80Carcinoma, Non-Small-Cell Lung 80Lung Neoplasms 67Colorectal Neoplasms 47Carcinoma, Hepatocellular 37Stomach Neoplasms 32Multiple Myeloma 29Brain Neoplasms 28Uterine Cervical Neoplasms 27Pancreatic Neoplasms 26Ovarian Neoplasms 26Melanoma 25Head and Neck Neoplasms 25Rectal Neoplasms 24Colonic Neoplasms 24Urinary Bladder Neoplasms 22Neoplasm Metastasis 21Hematologic Neoplasms 21Carcinoma, Renal Cell 20Leukemia, Myeloid, Acute 19Esophageal Neoplasms 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Endometrial Neoplasms 17Recurrence 15Lymphoma 15Liver Neoplasms 15Cardiovascular Diseases 15COVID-19 15

Interventions

Staining and Labeling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Observational × Hyperaldosteronism × Clear all
NCT05446779 2024-04-16

SuddenDeath

Helsinki University Central Hospital

Active not recruiting
400 enrolled
Endocrine

ACTH Syndrome, Ectopic, Endocrine Gland Neoplasms, Hyperaldosteronism, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡